Financial Performance Summary

Deccan Health Care Limited reported strong financial results for FY 2025-26 with significant growth across key metrics. Standalone revenue increased by 18.7% to ₹891.71 crore from ₹751.38 crore in FY25, while standalone net profit (PAT) surged 91.2% to ₹22.90 crore from ₹11.98 crore. Consolidated performance was even stronger with revenue reaching ₹819.14 crore and PAT jumping 114.7% to ₹248.76 lakh.

Capital Structure & Corporate Actions

The company strengthened its capital base by issuing 1,323,667 equity shares through conversion of convertible warrants at ₹30 per share (₹10 face value + ₹20 premium), raising ₹397.10 lakh. This increased the paid-up share capital to ₹2,474.92 lakh. The 30th Annual General Meeting is scheduled for September 30, 2026, to adopt financial statements and reappoint director Umanja Venkata Satya Siva Srihari Kolla.

Regulatory Compliance Issues

The company faced regulatory challenges with SEBI imposing fines totaling ₹9.45 lakh for multiple LODR violations:

  • Delayed appointment of qualified company secretary as compliance officer (₹3,540 fine, paid)
  • Non-compliance with board composition requirements (fines of ₹5,07,400 and ₹4,18,900, waiver applications filed)
  • Delayed constitution of nomination and remuneration committee (₹1,03,840 fine, waiver application filed)

Business Operations & Strategy

Deccan Health Care expanded its product portfolio into weight wellness, hydration, and sports nutrition categories. The company progressed international expansion with UAE product registration completed and first export consignment expected in FY 2026-27. The company operates through subsidiaries including Beyoungstore Private Limited (e-commerce) and Deccan Better Living INC (US operations, yet to commence).

Financial Position & Ratios

Key financial metrics showed improvement with current ratio at 3.81 times, debt-equity ratio at 0.04 times, and net profit ratio improving to 3.04% from 1.54%. Property, plant and equipment stood at ₹3,576.80 lakh gross block with net block of ₹1,499.81 lakh. Contingent liabilities included ₹1,870.90 lakh for income tax matters and defined benefit obligations of ₹48.90 lakh for gratuity.

Related Party Transactions & Management

Transactions with related parties included sales of ₹1,567.47 lakh to Beyoung Store and purchases of ₹314.59 lakh. Director remuneration totaled ₹202.44 lakh, with Dr. Minto P Gupta receiving ₹117.00 lakh and Mohak M Gupta receiving ₹49.92 lakh. The company had 80 permanent employees with average salary increases of 24.86% for non-managerial staff and 25.43% for KMPs.

Auditor's Report & Governance

The financial statements received unmodified audit opinions from Keyur Shah & Associates, with revenue recognition identified as a key audit matter. The board composition includes Dr Minto Purshotam Gupta as Chairman & Managing Director along with nine other directors, maintaining appropriate governance structures despite the regulatory challenges.